GFAP and Alzheimer disease: In this study, we show that IP-MS Aβ42/40 have high accuracy in the detection of Aβ pathology at all stages of the AD continuum and, in combination with GFAP and p-tau181, had a very high accuracy to determine Aβ-positivity in CI (> 93%).